Marrone Bio Innovations Inc

MBIICIK 0001441693 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 9, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0046Δ-0.001038% similar+916/-351 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.10pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Marrone Bio Innovations Inc

Name	Roles	Filings
Marrone Pamela G	Director	3
Cheung Suping (Sue)	Officer	2
Helash Kevin	OfficerDirector	2
Johnson Timothy B	Officer	2
Lee Lara L	Director	2

Showing 1-5 of 13

Per pagePage 1 of 3Next

All filings

27 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 13, 2022	Marrone Pamela G Director	SSale	20,492	$1.1771	$24,121
May 25, 2022	Marrone Pamela G Director	SSale	21,009	$1.148	$24,118
Apr 8, 2022	Lee Lara L Director	Holdings only	-	-	-
Apr 8, 2022	Woolf Stuart Director	Holdings only	-	-	-
Apr 8, 2022	Woods Robert A Director	Holdings only	-	-	-

Showing 1-5 of 27

Per pagePage 1 of 6Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value